Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New flu vaccine formulas show promise in early trial

NCT ID NCT04451954

First seen Sep 30, 2025 · Last updated May 21, 2026 · Updated 22 times

Summary

This study tested several new versions of a quadrivalent (four-strain) flu vaccine in 210 healthy adults aged 18 and older. The goal was to see if the vaccines were safe and how well they triggered the immune system to produce antibodies against influenza. Some formulas included an adjuvant (an ingredient to boost immune response) and different H3 antigens. The study is complete and provides early safety and immune data.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Investigational Site Number 8400001

    Peoria, Illinois, 61614, United States

  • Investigational Site Number 8400002

    Melbourne, Florida, 32934, United States

  • Investigational Site Number 8400003

    San Diego, California, 92108, United States

  • Investigational Site Number 8400004

    Orlando, Florida, 32806, United States

  • Investigational Site Number 8400005

    Rockville, Maryland, 20850, United States

Conditions

Explore the condition pages connected to this study.